ICCM · IceCure Medical Ltd.
$3.02
+0.02 (+0.67%)
At close · Aug 14
Market Cap
$10.35M
Shares
3.43M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$3.38M
+2.7%
FY2025
Net Income
-$15.06M
+1.7%
FY2025
Gross Margin
36.28%
-7.8pp
FY2025
Operating Margin
-446.7%
+30.2pp
FY2025
Diluted EPS
$7.20
-20%
FY2025
Operating Cash Flow
-$14.57M
-16%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| $3.38M | $3.29M | $3.23M | $3.09M | $4.14M | $3.87M | $1.63M | |
| $2.15M | $1.84M | $1.93M | $1.64M | $1.94M | $1.42M | $1.1M | |
| $1.23M | $1.45M | $1.3M | $1.45M | $2.2M | $2.44M | $524K | |
| 36.28% | 44.09% | 40.26% | 46.84% | 53.04% | 63.19% | 32.21% | |
| $7.43M | $7.1M | $8.27M | $9.12M | $5.88M | $3.81M | $3M | |
| $4.36M | $6.3M | $4.44M | $3.2M | $1.92M | $1.06M | $1.04M | |
| $4.53M | $3.76M | $4.17M | $5.86M | $4.13M | $1.71M | $1.27M | |
| — | — | — | $735K | $177K | $120K | — | |
| -$15.09M | -$15.7M | -$15.58M | -$16.74M | -$9.72M | -$4.14M | -$4.78M | |
| -446.7% | -476.94% | -482.38% | -542.59% | -234.99% | -107.08% | -294.04% | |
| $37K | $378K | $924K | -$239K | -$171K | $412K | $233K | |
| -$15.06M | -$15.32M | -$14.65M | -$16.98M | -$9.9M | -$3.73M | -$4.55M | |
| -445.61% | -465.45% | -453.76% | -550.34% | -239.13% | -96.43% | -279.72% | |
| USD/shares | $7.20 | $9.00 | $9.60 | $13.80 | $10.50 | $6.60 | $9.90 |
| USD/shares | $7.20 | $9.00 | $9.60 | $13.80 | $10.50 | $6.60 | $9.90 |
| shares | 2.12M | 1.7M | 1.52M | 1.23M | 951.62K | 570.96K | 454.04K |
| shares | 2.12M | 1.7M | 1.52M | 1.23M | 951.62K | 570.96K | 454.04K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Other Countries | $1,937,000 | $1,456,000 | $1,419,000 | $1,170,000 | $1,215,000 |
| United States | $908,000 | $870,000 | $751,000 | $604,000 | $471,000 |
| Japan | $282,000 | $481,000 | $480,000 | $1,130,000 | $1,380,000 |
| India | $120,000 | $413,000 | $109,000 | $47,000 | — |
| China | $108,000 | $41,000 | $440,000 | $104,000 | — |
| Israel | $24,000 | $30,000 | $30,000 | $30,000 | $108,000 |
| Thailand | — | — | — | $30,000 | $964,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Disposables | $2,053,000 | $1,828,000 | $1,503,000 | $1,336,000 | $1,208,000 |
| Systems | $1,326,000 | $1,363,000 | $1,452,000 | $1,002,000 | $1,560,000 |
| Exclusive Distribution Agreement | — | $100,000 | $274,000 | $747,000 | $1,370,000 |
Key facts
CIK
1584371
CUSIP
M53071201
13F (30d)
12 filings
12 filers
Visit website
Investor relations